Skip to content

Prospective multi-center multi-omics study of diseases in pregnancy

Prospective multi-center multi-omics study of diseases in pregnancy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088847
Enrollment
Unknown
Registered
2024-08-28
Start date
2022-12-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases in pregnancy

Interventions

Pregnant women with preeclampsia/premature delivery/gestational diabetes/cholestasis of pregnancy/fetal growth restriction:None

Sponsors

Chongqing Health Center for Women and Children
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Singleton; age 18-45 years old; 2. The one who has a fixed residence in the city where she receives antenatal care; 3. The object of study shall have prenatal examinations during pregnancy and plan to give birth in the recruitment and research settings.

Exclusion criteria

Exclusion criteria: 1. IVF pregnancy; 2. Pregnant women with twins or multiplets; 3. Patients with severe cardiac, liver and renal insufficiency; Patients with autoimmune diseases and malignant tumor diseases; 4. Polyploid, or large foetal defects, or termination of pregnancy, miscarriage or foetal death before 24 weeks; 5. Pregnant women were not followed up after 20 weeks of pregnancy, lacking clinical information and delivery outcomes.

Design outcomes

Primary

MeasureTime frame
Incidence rate of preeclampsia, preterm birth, gestational diabetes, etc;

Secondary

MeasureTime frame
Incidence of adverse pregnancy outcomes;

Countries

China

Contacts

Public ContactHongbo Qi

Chongqing Health Center for Women and Children

qihongbo728@163.com+86 23 6380 9721

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026